Cargando…

Identification of Molecular Targets and Anti-Cancer Agents in GBM: New Perspectives for Cancer Therapy

Detalles Bibliográficos
Autores principales:	D’Amico, Agata Grazia, Caruso Bavisotto, Celeste, Virtuoso, Assunta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377218/ https://www.ncbi.nlm.nih.gov/pubmed/37509010 http://dx.doi.org/10.3390/brainsci13071078

Ejemplares similares

Role of Molecular Chaperones in Carcinogenesis: Mechanism, Diagnosis, and Treatment
por: Conway de Macario, Everly, et al.
Publicado: (2020)

Molecular Target and Action Mechanism of Anti-Cancer Agents
por: Lee, Seok-Geun
Publicado: (2023)

Molecular Pathways Implicated in Radioresistance of Glioblastoma Multiforme: What Is the Role of Extracellular Vesicles?
por: Burko, Pavel, et al.
Publicado: (2023)

Anti-GBM-Nephritis
por: Windpessl, Martin, et al.
Publicado: (2023)

Air Pollution: Role of Extracellular Vesicles-Derived Non-Coding RNAs in Environmental Stress Response
por: D’Amico, Giuseppa, et al.
Publicado: (2023)

Re-thinking the preclinical development of GBM therapeutics
por: Cosset, Érika, et al.
Publicado: (2018)

Anti-GBM disease with a mild relapsing course and low levels of anti-GBM autoantibodies
por: Segelmark, Mårten, et al.
Publicado: (2012)

The role of neurosurgery in medulla oblongata GBM, a challenge
por: Fahlbusch, Rudolf
Publicado: (2019)

Transformation of membranous into anti-GBM nephritis
por: Imtiaz, S., et al.
Publicado: (2012)

Novel Anti-Cancer Agents and Cellular Targets and Their Mechanism(s) of Action
por: Allison, Simon J.
Publicado: (2022)

Migration-Associated Transportome and Therapeutic Potential in Glioblastoma Multiforme (GBM)
por: Vaid, Samir, et al.
Publicado: (2023)

Anti-GBM disease with positive serum anti-GBM antibodies but negative IgG deposition: A case report
por: Kazemzadeh, Kimia, et al.
Publicado: (2023)

Editorial: Physiology and Pathophysiology of Heat Shock Protein 60
por: Marino Gammazza, Antonella, et al.
Publicado: (2020)

Crescentic Glomerulonephritis with Anti-GBM and p-ANCA Antibodies
por: Javed, Tariq, et al.
Publicado: (2012)

Recurrent anti-GBM disease with pulmonary artery aneurysms
por: Dixon, John, et al.
Publicado: (2016)

Crescentic glomerulonephritis with anti-GBM antibody but no glomerular deposition
por: Sadeghi-Alavijeh, Omid, et al.
Publicado: (2018)

Benzenesulfonamide Analogs: Synthesis, Anti-GBM Activity and Pharmacoprofiling
por: Murugesan, Akshaya, et al.
Publicado: (2023)

Molecular Imaging: In Vivo Agents for the Diagnosis and Treatment of Cancer
por: Haeusler, D., et al.
Publicado: (2018)

Histone H3 Phosphorylation in GBM: a New Rational to Guide the Use of Kinase Inhibitors in anti-GBM Therapy
por: Pacaud, Romain, et al.
Publicado: (2015)

The “Journal of Functional Morphology and Kinesiology” Journal Club Series: Highlights on Recent Papers in Overtraining and Exercise Addiction
por: Bianco, Antonino, et al.
Publicado: (2019)

Cancer stem cells and macrophages: molecular connections and future perspectives against cancer
por: Aramini, Beatrice, et al.
Publicado: (2021)

Visualizing Molecular Profiles of Glioblastoma with GBM-BioDP
por: Celiku, Orieta, et al.
Publicado: (2014)

Heat Shock Proteins in Alzheimer’s Disease: Role and Targeting
por: Campanella, Claudia, et al.
Publicado: (2018)

A Case of Simultaneous, Biopsy-Proven, Classic, ANCA-Positive Wegener's Granulomatosis and Anti-GBM Disease, but without Detectible Circulating Anti-GBM Antibodies
por: Gmurczyk, Aleksandra, et al.
Publicado: (2010)

Targeted Proteomics to Assess the Response to Anti-Angiogenic Treatment in Human Glioblastoma (GBM)
por: Demeure, Kevin, et al.
Publicado: (2016)

The Role of Molecular Chaperones in Virus Infection and Implications for Understanding and Treating COVID-19
por: Paladino, Letizia, et al.
Publicado: (2020)

Mental health care in oncology. Contemporary perspective on the psychosocial burden of cancer and evidence-based interventions
por: Caruso, R., et al.
Publicado: (2020)

Repurposing an anti‐cancer agent for the treatment of hypertrophic heart disease
por: Dukinfield, Matthew, et al.
Publicado: (2019)

Editorial: Uveal melanoma: from lab bench to clinic – new therapeutic advances
por: D'Amico, Agata Grazia, et al.
Publicado: (2023)

Pulmonary-Renal Syndrome with Negative ANCAs and Anti-GBM Antibody
por: Yamaguchi, Hiroshi, et al.
Publicado: (2013)

Rescue of kidney function in a toddler with anti-GBM nephritis
por: Bjerre, Anna, et al.
Publicado: (2012)

Anti-GBM antibody disease sans crescents with thrombotic microangiopathy
por: Gowrishankar, Swarnalata, et al.
Publicado: (2009)

A case report of double negative anti-GBM disease
por: Kheiri, Babikir, et al.
Publicado: (2019)

Triggering anti-GBM immune response with EGFR-mediated photoimmunotherapy
por: Mączyńska, Justyna, et al.
Publicado: (2022)

Pembrolizumab-Induced Anti-GBM Glomerulonephritis: A Case Report
por: El Yamani, Nidal, et al.
Publicado: (2023)

Ginger and its active constituents as therapeutic agents: Recent perspectives with molecular evidences
por: Rasheed, Naila
Publicado: (2020)

Biomimetic GBM-targeted drug delivery system boosting ferroptosis for immunotherapy of orthotopic drug-resistant GBM
por: Liu, Bao, et al.
Publicado: (2022)

Targeted Molecular Therapy in Glioblastoma
por: Festuccia, Claudio, et al.
Publicado: (2020)

Immunobiology of Solid Cancers: Cellular and Molecular Pathways as Potential Diagnostic and Therapeutic Targets
por: Ruscito, Ilary, et al.
Publicado: (2018)

Pseudo-AKI associated with targeted anti-cancer agents—the truth is in the eye of the filtration marker
por: Vanhoutte, Thomas, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_i4dpptq2qej99uc2epv6scmulp